Karsen Perry A is a director of LENZ Therapeutics, Inc.
Person profile
Roles
LENZ Therapeutics
Director
Jounce Therapeutics
Director
Address
Summit, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Graphite Bio, Inc.
21 Jul 23
4
Jounce Therapeutics, Inc.
4 May 23
4
Jounce Therapeutics, Inc.
28 Jun 22
4
Graphite Bio, Inc.
22 Jun 22
4
Graphite Bio, Inc.
1 Jul 21
3
Graphite Bio, Inc.
24 Jun 21
4
Jounce Therapeutics, Inc.
22 Jun 21
4
Intellia Therapeutics, Inc.
18 Dec 20
3
Jiya Acquisition Corp.
18 Nov 20
4/A
Jounce Therapeutics, Inc.
2 Jul 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Jul 23 | LENZ LENZ Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.72 | 20,000 | 54.40 k | 20,000 |
3 May 23 | JNCE Jounce Therapeutics | Common Stock | Dispose U | No | No | 0 | 5,000 | 0.00 | 0 | |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.8 | 20,000 | 56.00 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.27 | 15,700 | 114.14 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.58 | 15,700 | 119.01 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.46 | 15,700 | 70.02 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.92 | 13,350 | 105.73 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.56 | 16,260 | 155.45 k | 0 |
3 May 23 | JNCE Jounce Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.06 | 75,880 | 308.07 k | 0 |